A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
We deliver transformative solutions that power real results. See how we can help.
Optimizing Supply Chain
Maximizing Value-Based Care
Transforming healthcare is more than our objective, it’s in our DNA. We’re dedicated to ensuring better health is just the beginning.
Guided by our values, our employees work every day to make meaningful differences in healthcare. At the core of what we do is our most valuable resource - our people. Learn more about us.
Board of Directors
Premier is more than a GPO. Combining robust analytics with consulting and advocacy, we’re changing the healthcare landscape for the better.
Find Out How
Collective purchasing power lowers costs across your organization.
Intelligence plus unparalleled analytics equals data-driven solutions.
It’s only impossible until it’s not. Premier and our team of experts are transforming care delivery.
Work with Premier members to lower costs, improve quality and safety and succeed in value-based care.
A voice for better healthcare policy is a voice for you.
Working closely with our members, we’re developing products and services to solve your most complex challenges.
Lower costs, greater efficiencies and a healthier bottom line.
Proven practices that result in better outcomes.
Intersecting specialty drugs with better management and data-driven best practices.
Controlling your future with integrated care delivery practices.
More savings and ROI is a win-win.
Data diving to deliver insights you can act on.
Supporting healthcare transformation through the generation of real-world evidence.
Working closely with our members, we're developing products and services to solve your most complex challenges.
Our most recent insights, articles and more, all in one place.
View Our Latest
Discover what leading healthcare providers are achieving through Premier membership.
Stay informed with our white papers, webinars and e-books.
Browse our blog for a taste of what’s new and what’s next in healthcare.
Premier’s perspectives have been solicited by nationally renowned publications. Read on.
Read Premier’s latest announcements.
Catch our policy statements and perspectives on the latest in DC.
Compelling stories from the front lines of America’s health systems.
The proactive, predictive and behind-the-scenes insights you need to stay ahead in healthcare delivered monthly to your inbox.
A resource hub for all things Premier.
Find what you’re looking for, fast! Select a category or topic to get to what matters to you most.
Wall Street Journal |
It will take years to repatriate the R&D assignments farmed out to the lowest-cost bidder.
The PHD provides a deeper set of insights into diseases allowing researchers to run stronger analyses and help to predict future trends and outbreaks.
Premier recommends actions the federal government can take to better prepare the nation for Monkeypox and future public health emergencies.
Premier urges CMS to adequately reimburse hospitals, provide a remedy for 340B drug cuts and adjust payments for domestically-produced N95s.
To improve healthcare outcomes, we must focus our efforts on reducing harm, driving clinical quality improvements, advancing health equity and reducing disparities for all.
Bite back with Remitra™ Cash Flow Optimizer (CFO) technology.
The acquisition will support Contigo Health’s continued growth by expanding its nationwide footprint and enhancing the value proposition for direct-to-employer offerings.
Partnership will provide a better view of patient journey by connecting disparate datasets while preserving patient privacy to help improve quality and reduce costs.
While boosters can be a game changer, we cannot repeat some of the same early pandemic mistakes.
Despite high U.S. maternal mortality, pregnancy is woefully under-researched. Thanks to the pandemic, technology that makes it easier to study pregnancy is catching up.
The U.S. Congress typically pins the high cost of healthcare on the pharmaceutical industry, citing sometimes exorbitant prices for disease-modifying therapies. But drug prices are...
While we’ve made some progress, unfortunately, it appears we still have work to do.